Evidence map›Paper›PMID 19684113›Full record

ArticleGenes & development2009

Characterization of the rapamycin-sensitive phosphoproteome reveals that Sch9 is a central coordinator of protein synthesis.

Alexandre Huber, Bernd Bodenmiller, Aino Uotila, Michael Stahl, Stefanie Wanka, Bertran Gerrits, Ruedi Aebersold, Robbie Loewith

Abstract read
In one paragraph

Article in Genes & development, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 210 papers.

0numbers the graph read from it
0cells of the map it votes in
210citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

210 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Integrative Phosphoproteomic and Proteomic Analysis ofJournal of proteome research · 2025
    Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Experimental evolution ofbioRxiv : the preprint server for biology · 2024
    Article
  16. Article
  17. Article
  18. TOR Complex 1: Orchestrating Nutrient Signaling and Cell Cycle Progression.International journal of molecular sciences · 2023
    Review
  19. An Observatory for theCancers · 2023
    Review
  20. Article

150 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alexandre HuberDepartment of Molecular Biology, University of Geneva, Geneva, Switzerland.
Bernd Bodenmiller
Aino Uotila
Michael Stahl
Stefanie Wanka
Bertran Gerrits
Ruedi Aebersold
Robbie Loewith

Funding

NHLBI PROTEOMICS INITIATIVE-268028179N01HV028179 · HV · INSTITUTE FOR SYSTEMS BIOLOGY · 2002 to 2002
–
European Research Council 206173NHLBI NIH HHS N01 HV028179NHLBI NIH HHS N01-HV-28179
6 · The paper itself

Abstract

The target of rapamycin complex 1 (TORC1) is an essential multiprotein complex conserved from yeast to humans. Under favorable growth conditions, and in the absence of the macrolide rapamycin, TORC1 is active, and influences virtually all aspects of cell growth. Although two direct effectors of yeast TORC1 have been reported (Tap42, a regulator of PP2A phosphatases and Sch9, an AGC family kinase), the signaling pathways that couple TORC1 to its distal effectors were not well understood. To elucidate these pathways we developed and employed a quantitative, label-free mass spectrometry approach. Analyses of the rapamycin-sensitive phosphoproteomes in various genetic backgrounds revealed both documented and novel TORC1 effectors and allowed us to partition phosphorylation events between Tap42 and Sch9. Follow-up detailed characterization shows that Sch9 regulates RNA polymerases I and III, the latter via Maf1, in addition to translation initiation and the expression of ribosomal protein and ribosome biogenesis genes. This demonstrates that Sch9 is a master regulator of protein synthesis.

Indexed as

ProteomeAdaptor Proteins, Signal TransducingAntifungal AgentsCycloheximidePhosphorylationProtein BindingProtein BiosynthesisProtein Serine-Threonine KinasesProtein Synthesis InhibitorsProtein TransportRNA Polymerase IRNA Polymerase IIISaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSignal TransductionSirolimusAdaptor Proteins, Signal TransducingAntifungal AgentsCycloheximideMAF1 protein, S cerevisiaeProtein Serine-Threonine KinasesProtein Synthesis InhibitorsProteomeRNA Polymerase IRNA Polymerase IIISaccharomyces cerevisiae ProteinsSCH9 protein, S cerevisiaeSirolimusTAP42 protein, S cerevisiaeTranscription Factors

Identifiers

PMID19684113
PMCPMC2725941

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.